Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies
Go back to Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies| Baxter International Inc. (NYSE: BAX) | Delayed: 24.76 +0.41 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.35 | 52 Week High | $50.16 | |||
| Open | $24.44 | 52 Week Low | $34.06 | |||
| Day High | $24.78 | P/E | 6.77 | |||
| Day Low | $24.34 | EPS | $3.66 | |||
| Volume | 2,001,444 | |||||



